Cell cycle-related phosphatases CDC25A and B expression correlates with survival in ovarian cancer patients
- PMID: 11205229
Cell cycle-related phosphatases CDC25A and B expression correlates with survival in ovarian cancer patients
Abstract
Alterations in cell cycle regulating proteins are common in many cancer types. Recent data suggest a possible link between CDC25 phosphatases overexpression and malignancy. Our objective was to evaluate the expression of the three cell cycle-related phosphatases CDC25A, CDC25B and CDC25C in patients with ovarian cancer. All the patients had a minimal follow up of three years. CDC25A, CDC25B and CDC25C expression were investigated by immunohistochemistry in 106 patients with ovarian cancer. CDC25A and CDC25B were found expressed in almost all the samples analyzed, while CDC25C was undetectable in more than 80% of the patients. The low evaluable data on CDC25C expression, did not allow any association between the expression of this phosphatase and prognosis. The expression of CDC25A and CDC25B showed some evidences of association with a poor prognosis (p = 0.034 and p = 0.058 respectively). This relationship was independent of other factors such as tumor grade, histotype, stage and residual tumor after surgery. In the same patients the examined parameters (residual tumor, grade, stage and histotype) did show the expected relation with survival. The results indicate that high CDC25A and CDC25B expression is related to a worse prognosis in ovarian cancer patients. CDC25 phosphatases expression can be regarded as a possible prognostic factor for ovarian cancer and these proteins should be evaluated as potential molecular _targets of novel drugs against this human neoplasm.
Similar articles
-
[Clinical characteristics and prognosis of epithelial ovarian cancer in young women].Ai Zheng. 2008 Sep;27(9):951-5. Ai Zheng. 2008. PMID: 18799034 Chinese.
-
Expression of cdc25A and cdc25B phosphatase in breast carcinoma.Breast Cancer. 2004;11(3):295-300. doi: 10.1007/BF02984552. Breast Cancer. 2004. PMID: 15550849
-
Overexpression of CDC25A phosphatase is associated with hypergrowth activity and poor prognosis of human hepatocellular carcinomas.Clin Cancer Res. 2003 May;9(5):1764-72. Clin Cancer Res. 2003. PMID: 12738732
-
[Prognostic factors of ovarian cancer].Gan To Kagaku Ryoho. 2006 Dec;33(13):2014-9. Gan To Kagaku Ryoho. 2006. PMID: 17197745 Review. Japanese.
-
Cell cycle control by the CDC25 phosphatases.Anticancer Agents Med Chem. 2008 Dec;8(8):818-24. doi: 10.2174/187152008786847756. Anticancer Agents Med Chem. 2008. PMID: 19075563 Review.
Cited by
-
CDC25A(Q110del): a novel cell division cycle 25A isoform aberrantly expressed in non-small cell lung cancer.PLoS One. 2012;7(10):e46464. doi: 10.1371/journal.pone.0046464. Epub 2012 Oct 5. PLoS One. 2012. PMID: 23071577 Free PMC article.
-
Cellular prostatic acid phosphatase, a PTEN-functional homologue in prostate epithelia, functions as a prostate-specific tumor suppressor.Biochim Biophys Acta. 2014 Aug;1846(1):88-98. doi: 10.1016/j.bbcan.2014.04.006. Epub 2014 Apr 18. Biochim Biophys Acta. 2014. PMID: 24747769 Free PMC article. Review.
-
Potential of CDC25 phosphatases in cancer research and treatment: key to precision medicine.Front Pharmacol. 2024 Jan 19;15:1324001. doi: 10.3389/fphar.2024.1324001. eCollection 2024. Front Pharmacol. 2024. PMID: 38313315 Free PMC article. Review.
-
High LIN28A and PLK4 co‑expression is associated with poor prognosis in epithelial ovarian cancer.Mol Med Rep. 2018 Dec;18(6):5327-5336. doi: 10.3892/mmr.2018.9562. Epub 2018 Oct 16. Mol Med Rep. 2018. PMID: 30365085 Free PMC article.
-
Effects of let-7c on the proliferation of ovarian carcinoma cells by _targeted regulation of CDC25a gene expression.Oncol Lett. 2018 Nov;16(5):5543-5550. doi: 10.3892/ol.2018.9327. Epub 2018 Aug 20. Oncol Lett. 2018. PMID: 30405749 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical
Research Materials
Miscellaneous